Cargando…
Inhibition of the mitochondria-shaping protein Opa1 restores sensitivity to Gefitinib in a lung adenocarcinomaresistant cell line
Drug resistance limits the efficacy of chemotherapy and targeted cancer treatments, calling for the identification of druggable targets to overcome it. Here we show that the mitochondria-shaping protein Opa1 participates in resistance against the tyrosine kinase inhibitor gefitinib in a lung adenoca...
Autores principales: | Noguchi, Masafumi, Kohno, Susumu, Pellattiero, Anna, Machida, Yukino, Shibata, Keitaro, Shintani, Norihito, Kohno, Takashi, Gotoh, Noriko, Takahashi, Chiaki, Hirao, Atsushi, Scorrano, Luca, Kasahara, Atsuko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10076284/ https://www.ncbi.nlm.nih.gov/pubmed/37019897 http://dx.doi.org/10.1038/s41419-023-05768-2 |
Ejemplares similares
-
Inhibition of the mitochondrial protein Opa1 curtails breast cancer growth
por: Zamberlan, Margherita, et al.
Publicado: (2022) -
OPA1, a new mitochondrial target in cancer therapy
por: Herkenne, Stephanie, et al.
Publicado: (2020) -
Cancer stem-like properties and gefitinib resistance are dependent on purine synthetic metabolism mediated by the mitochondrial enzyme MTHFD2
por: Nishimura, Tatsunori, et al.
Publicado: (2018) -
Essential role of autophagy in protecting neonatal haematopoietic stem cells from oxidative stress in a p62-independent manner
por: Nomura, Naho, et al.
Publicado: (2021) -
The antiapoptotic OPA1/Parl couple participates in mitochondrial adaptation to heat shock()
por: Sanjuán Szklarz, Luiza K., et al.
Publicado: (2012)